Advertisement
Loading...

InflaRx N.V.

IFRX•NASDAQ
Healthcare
Biotechnology
$2.52
$0.09(3.70%)
U.S. Market opens in 4h 44m

InflaRx N.V. (IFRX) Stock Overview

Explore InflaRx N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap182.2M
P/E Ratio-3.89
EPS (TTM)$-0.74
ROE-0.91%
Fundamental Analysis

AI Price Forecasts

1 Month$0.66
3 Months$0.00
1 Year Target$1.04

IFRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of InflaRx N.V. (IFRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.77, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $1.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.89 and a market capitalization of 182.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.70%
5-Day Change
-3.82%
1-Month Change
135.51%
3-Month Change
193.09%
6-Month Change
98.43%
Year-to-Date (YTD) Change
149.50%
1-Year Change
40.78%
3-Year Change
-47.93%
5-Year Change
-7.35%
All-Time (Max) Change
-83.20%

Contact Information

https://www.inflarx.de
49 3641 508 180
Winzerlaer Str. 2, Jena, NaN, 07745

Company Facts

74 Employees
IPO DateNov 7, 2017
CountryDE
Actively Trading

Frequently Asked Questions